Subcutaneous daratumumab in Asian patients with heavily pretreated multiple myeloma: subgroup analyses of the noninferiority, phase 3 COLUMBA study

  1. Iida, S.
  2. Ishikawa, T.
  3. Min, C.K.
  4. Kim, K.
  5. Yeh, S.P.
  6. Usmani, S.Z.
  7. Mateos, M.-V.
  8. Nahi, H.
  9. Heuck, C.
  10. Qin, X.
  11. Parasrampuria, D.A.
  12. Gries, K.S.
  13. Qi, M.
  14. Bahlis, N.
  15. Ito, S.
Aldizkaria:
Annals of Hematology

ISSN: 1432-0584,  0939-5555

Argitalpen urtea: 2021

Alea: 100

Zenbakia: 4

Orrialdeak: 1065-1077

Mota: Artikulua

DOI: 10.1007/S00277-021-04405-2 GOOGLE SCHOLAR lock_openSarbide irekia editor